221 Effectiveness of Opt-Out, Non-Targeted Human Immunodeficiency Virus and Hepatitis C Virus Testing in an Urban Emergency Department

2018 ◽  
Vol 72 (4) ◽  
pp. S88
Author(s):  
J.D. Tankersley ◽  
W. Edwards ◽  
M. Burgett-Moreno ◽  
R. Borger
Keyword(s):  
Emergency Department ◽  
Human Immunodeficiency Virus ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Opt Out ◽  
Immunodeficiency Virus ◽  
Virus Testing ◽  
Urban Emergency Department

scholarly journals Bundling Rapid Human Immunodeficiency Virus and Hepatitis C Virus Testing to Increase Receipt of Test Results

Medical Care ◽  
2020 ◽  
Vol 58 (5) ◽  
pp. 445-452
Author(s):  
Jemima A. Frimpong ◽  
Karen Shiu-Yee ◽  
Susan Tross ◽  
Thomas D’Aunno ◽  
David C. Perlman ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Test Results ◽  
Immunodeficiency Virus ◽  
Virus Testing

scholarly journals Hepatitis C Virus Testing Among Men With Human Immunodeficiency Virus Who Have Sex With Men: Temporal Trends and Racial/Ethnic Disparities

2021 ◽  
Vol 8 (4) ◽  
Author(s):  
Jun Li ◽  
Carl Armon ◽  
Frank J Palella ◽  
Ellen Tedaldi ◽  
Richard M Novak ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Hcv Infection ◽  
Immunodeficiency Virus ◽  
Hcv Antibody ◽  
Race Ethnicity ◽  
Sex With Men ◽  
Hcv Testing ◽  
Virus Testing

Abstract Background National guidelines recommend that sexually active people with human immunodeficiency virus (PWH) who are men who have sex with men (MSM) be tested for hepatitis C virus (HCV) infection at least annually. Hepatitis C virus testing rates vary by race/ethnicity in the general population, but limited data are available for PWH. Methods We analyzed medical records data from MSM in the HIV Outpatient Study at 9 human immunodeficiency virus (HIV) clinics from January 1, 2011 through December 31, 2019. We excluded observation time after documented past or current HCV infection. We evaluated HCV antibody testing in each calendar year among HCV-seronegative MSM, and we assessed testing correlates by generalized estimating equation analyses. Results Of 1829 eligible MSM who were PWH, 1174 (64.2%) were non-Hispanic/Latino white (NHW), 402 (22.0%) non-Hispanic black (NHB), 187 (10.2%) Hispanic/Latino, and 66 (3.6%) of other race/ethnicity. Most were ≥40 years old (68.9%), privately insured (64.5%), with CD4 cell count/mm3 (CD4) ≥350 (77.0%), and with HIV viral load <200 copies/mL (76.9%). During 2011–2019, 1205 (65.9%) had ≥1 HCV antibody test and average annual HCV percentage tested was 30.3% (from 33.8% for NHB to 28.5% for NHW; P < .001). Multivariable factors positively associated (P < .05) with HCV testing included more recent HIV diagnosis, public insurance, lower CD4, prior chlamydia, gonorrhea, syphilis, or hepatitis B virus diagnoses, and elevated liver enzyme levels, but not race/ethnicity. Conclusions Although we found no disparities by race/ethnicity in HCV testing, low overall HCV testing rates indicate suboptimal uptake of recommended HCV testing among MSM in HIV care.

Effect of Human Immunodeficiency Virus on the Outcome of Hepatitis C Virus Infection

2001 ◽  
Vol 36 (3) ◽  
pp. 225-234
Author(s):  
Ramazan Idilman ◽  
Alessandra Colantoni ◽  
Nicola De Maria ◽  
James M. Harig ◽  
David H. van Thiel
Keyword(s):  
Human Immunodeficiency Virus ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Hepatitis C Virus Infection ◽  
Immunodeficiency Virus
Sign in / Sign up

Export Citation Format

Share Document